Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Do cancer patients fully understand clinical trial participation? A pilot study to assess informed consent and patient expectations

Do cancer patients fully understand clinical trial participation? A pilot study to assess... Background. Accepted practices of informed consent often result in suboptimal patient understanding of research studies.Methods. This pilot study aimed to assess trial-specific tailored materials, compared to a widely used generic booklet about clinical trials, randomly assigned to 118 candidates for cancer clinical trials. Study outcomes were: satisfaction with decision-making; satisfaction with materials; and subjective understanding of the clinical trial.Results. There were no major differences between groups. Participants rated tailored materials higher as a useful reference.Conclusions. Trial-specific materials hold utility for reference during clinical trials. Studies of informed consent are feasible, although important factors limit research. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Journal of Cancer Education Springer Journals

Do cancer patients fully understand clinical trial participation? A pilot study to assess informed consent and patient expectations

Loading next page...
 
/lp/springer-journals/do-cancer-patients-fully-understand-clinical-trial-participation-a-01KtHAJFCJ

References (21)

Publisher
Springer Journals
Copyright
Copyright © 2007 by American Association for Cancer Education
Subject
Biomedicine; Cancer Research; Pharmacology/Toxicology
ISSN
0885-8195
eISSN
1543-0154
DOI
10.1007/BF03174370
Publisher site
See Article on Publisher Site

Abstract

Background. Accepted practices of informed consent often result in suboptimal patient understanding of research studies.Methods. This pilot study aimed to assess trial-specific tailored materials, compared to a widely used generic booklet about clinical trials, randomly assigned to 118 candidates for cancer clinical trials. Study outcomes were: satisfaction with decision-making; satisfaction with materials; and subjective understanding of the clinical trial.Results. There were no major differences between groups. Participants rated tailored materials higher as a useful reference.Conclusions. Trial-specific materials hold utility for reference during clinical trials. Studies of informed consent are feasible, although important factors limit research.

Journal

Journal of Cancer EducationSpringer Journals

Published: Nov 16, 2009

There are no references for this article.